Chong Kun Dang Pharmaceutical종근당

Credit rating

• AA-NICE Investors Service · corporate bonds · Rated Jun 17, 2026
• AA-Korea Ratings · corporate bonds · Rated Jun 16, 2026
• A+NICE Investors Service · issuer rating · Rated Jun 12, 2020

Bonds outstanding

₩140B in 3 bonds

1. ≤6 months—
2. 6–12 months₩40B
3. 1–2 years—
4. 2–3 years₩70B
5. 3–5 years₩30B
6. Over 5 years—

We read bond filings from Oct 25, 2021; older bonds may be missing.

Due soon vs cash

Due in 6 months

₩0

Due in 12 months

₩40B

Cash and equivalents

₩192B

Cash from the 2026 H1 statements

How it has moved with rates and the won

Average move of the shares on days the factor changed, over the last year. Describes the past, not a forecast.

• −0.46% per 10 bp rise in KTB 3ysome link · correlation -0.12 over 253 days
• −0.38% per 1% rise in USD/KRWsome link · correlation -0.12 over 253 days